Traditionally, obesity is considered one of the major factors of metabolic syndrome (MetS) including insulin sensitivity, hyperinsulinemia, hyperglycemia, and hypertension. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.